Biotechnology API

  • High-Purity PN (Polynucleotide) – Regenerative DNA Polymer for Skin Repair and Anti-Aging Formulations

    High Purity Polynucleotide (PN) API for Aesthetic Regeneration & Cellular Renewal

    .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

    High Purity Polynucleotide (PN) API for Aesthetic Regeneration & Cellular Renewal

    Polynucleotide API GMP Certified for Skin Regeneration & Repair

    Our Pharmaceutical Grade Polynucleotide (PN) represents the cutting edge of regenerative biotechnology, offering unprecedented capabilities in tissue repair and cellular rejuvenation. This premium API consists of carefully selected DNA fragments derived through advanced biotechnological processes, creating a sophisticated network of polynucleotide chains that work in harmony with the body’s natural repair mechanisms. With molecular weights optimally distributed between 100-2000 kDa, our PN is engineered for superior bioavailability and sustained biological activity, making it an ideal active ingredient for advanced aesthetic medicine, regenerative skincare, and therapeutic applications.

    The scientific foundation of PN lies in its ability to interact with multiple cellular pathways simultaneously. Research demonstrates that polynucleotides function as signaling molecules that activate fibroblasts, stimulate collagen and elastin production, enhance extracellular matrix remodeling, and modulate inflammatory responses through sophisticated cytokine regulation. This multi-target approach results in significant improvements in skin density, elasticity, and overall tissue quality, while reducing visible signs of aging and accelerating recovery from aesthetic procedures. Clinical studies further validate PN’s remarkable capacity to improve skin hydration, reduce transepidermal water loss, and restore healthy skin barrier function through enhanced glycosaminoglycan synthesis.

    Manufactured under stringent quality systems with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our PN API guarantees exceptional purity, consistent biological activity, and reliable performance across all applications. Each batch undergoes rigorous testing for molecular weight distribution, biological activity, endotoxin levels, and sterility, ensuring it meets the highest pharmaceutical standards. Whether developing next-generation injectable rejuvenation treatments, advanced wound healing solutions, or premium cosmeceutical products, our Polynucleotide API provides the scientific foundation for innovative formulations that deliver visible, measurable, and sustainable results in competitive global markets.

      Request Product Information

      Please share your requirements below.



      * B2B inquiries only
      * Confidential information protected
      * No spam or marketing emails

      Read moreDone
    • High-Purity Insulin Degludec Side Chain – Pharmaceutical Intermediate for Long-Acting Insulin API Synthesis

      Insulin Degludec Side Chain API GMP Certified Intermediate for Long-acting Insulin

      .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

      Insulin Degludec Side Chain API GMP Certified Intermediate for Long-acting Insulin

      Insulin Degludec Side Chain Pharmaceutical Intermediate API Supplier

      Our Pharmaceutical Grade Insulin Degludec Side Chain represents a breakthrough in diabetes treatment technology, serving as the critical building block for next-generation long-acting insulin analogs. This sophisticated API intermediate features a unique hexadecanedioic acid structure that enables the formation of multi-hexamers upon subcutaneous injection, creating a stable depot that ensures ultra-smooth, peakless basal insulin delivery over more than 42 hours. The carefully engineered molecular design provides unparalleled pharmacokinetic profiles, significantly reducing both hypoglycemic events and dosing frequency compared to traditional basal insulins.

      Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our Insulin Degludec Side Chain guarantees exceptional purity, batch-to-batch consistency, and reliable performance in final formulations. Each batch undergoes rigorous analytical testing using advanced HPLC, MS, and NMR methodologies to verify structural integrity, chiral purity, and absence of process-related impurities. The side chain’s specific chemical properties facilitate efficient conjugation with insulin backbone molecules while maintaining excellent solubility characteristics and stability profiles.

      As diabetes prevalence continues to rise globally, the demand for safer, more effective basal insulin options has never been greater. Our high-purity side chain intermediate enables pharmaceutical manufacturers to develop advanced insulin degludec formulations that offer flexible dosing schedules, improved glycemic control, and enhanced patient quality of life. Whether developing innovative standalone insulin products or combination therapies with GLP-1 receptor agonists, our Insulin Degludec Side Chain API provides the foundational quality and technical excellence required for successful diabetes treatment innovations in competitive global markets.

        Request Product Information

        Please share your requirements below.



        * B2B inquiries only
        * Confidential information protected
        * No spam or marketing emails

        Read moreDone
      • Medical grade Crosslinked Sodium Hyaluronate Gel for dermal fillers, regenerative medicine, and aesthetic applications

        Medical Grade Crosslinked Sodium Hyaluronate Gel for Dermal Fillers & Joint Injection

        .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

        Medical Grade Crosslinked Sodium Hyaluronate Gel for Dermal Fillers & Joint Injection

        Crosslinked Sodium Hyaluronate Gel Medical Grade Filler Base

        Crosslinked Sodium Hyaluronate Gel (Medical Grade) represents the pinnacle of hyaluronic acid technology for advanced medical and aesthetic applications. Engineered through sophisticated multi-step crosslinking technology, this premium API forms a uniform, stable three-dimensional network structure with precisely controlled crosslinking density between 6%-8%. The result is a viscoelastic gel with exceptional longevity, demonstrating 6-18 months of in vivo persistence while maintaining ultralow BDDE residue levels below 1μg/ml.

        Specifically designed for precision aesthetic contouring, joint viscosupplementation, and minimally invasive anti-adhesion applications, our crosslinked HA gel redefines the gold standard in medical and aesthetic repair. Available in four specialized formulations targeting different tissue depths – Superficial, Middle, Deep, and Ultra-Deep layers – each variant features optimized particle size distribution (100-1000μm) and concentration (20-24mg/ml) to address specific clinical indications from fine line correction to advanced volume restoration.

        Manufactured in cGMP-certified facilities with comprehensive international certifications including FDA compliance and ISO 13485, we guarantee pharmaceutical-grade quality with ultra-low endotoxin levels and minimal crosslinker residues. Our technical expertise allows for complete customization of crosslinking density, particle size, and rheological properties to match your specific product requirements. Whether developing next-generation dermal fillers, viscosupplementation products, or advanced medical devices, our Crosslinked Sodium Hyaluronate Gel provides the perfect foundation for innovative solutions that demand both safety and performance excellence in global markets.

          Request Product Information

          Please share your requirements below.



          * B2B inquiries only
          * Confidential information protected
          * No spam or marketing emails

          Read moreDone
        • Medical grade Crosslinked Sodium Hyaluronate Powder for dermal fillers, skincare, and pharmaceutical applications

          Medical Grade Crosslinked Sodium Hyaluronate Powder API for Dermal Fillers & Injectables

          .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

          Medical Grade Crosslinked Sodium Hyaluronate Powder API for Dermal Fillers & Injectables

          Crosslinked Sodium Hyaluronate Powder cGMP Medical Grade API

          Our Medical Grade Crosslinked Sodium Hyaluronate Powder represents a breakthrough in hyaluronic acid technology, engineered specifically for the most demanding medical and aesthetic applications. This premium API is manufactured using advanced multi-step crosslinking technology with BDDE, precisely controlling crosslinking density between 6%-8% to achieve the optimal balance between longevity and biocompatibility. The innovative lyophilization process transforms the crosslinked gel into a stable powder that instantly rehydrates in physiological saline to restore its robust three-dimensional hydrogel network.

          This unique powder form offers unparalleled flexibility for manufacturers, enabling customized formulation of dermal fillers, intra-articular injections, and regenerative medicine products. The crosslinked matrix provides exceptional in vivo persistence from 6 to 18 months, making it ideal for applications requiring long-term tissue support and functional restoration. With ultralow endotoxin levels (<0.005 EU/mg) and minimal crosslinker residues, our product meets the strictest safety standards for injectable medical devices.

          Manufactured in cGMP-certified facilities with comprehensive international certifications including FDA compliance and ISO 13485, we guarantee pharmaceutical-grade quality and batch-to-batch consistency. Our technical expertise allows for complete customization of crosslinking density, particle size, and rheological properties to match your specific product requirements. Whether developing next-generation dermal fillers, viscosupplementation products, or drug delivery systems, our Crosslinked Sodium Hyaluronate Powder provides the perfect foundation for innovative medical solutions that demand both safety and performance excellence.

            Request Product Information

            Please share your requirements below.



            * B2B inquiries only
            * Confidential information protected
            * No spam or marketing emails

            Read moreDone
          • High-Purity PDRN (Polydeoxyribonucleotide) – Regenerative Nucleotide Raw Material for Skin Repair and Tissue Healing

            Pharmaceutical Grade PDRN (Polydeoxyribonucleotide) API for Skin Regeneration & Wound Healing

            .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

            Pharmaceutical Grade PDRN (Polydeoxyribonucleotide) API for Skin Regeneration & Wound Healing

            PDRN API GMP Certified Polydeoxyribonucleotide Raw Material

            Our Pharmaceutical Grade PDRN (Polydeoxyribonucleotide) represents a breakthrough in regenerative medicine and aesthetic science. Derived from carefully controlled biotechnological processes, this high-purity active pharmaceutical ingredient consists of DNA fragments with molecular weights ranging from 50 to 1500 kDa, optimized for maximum biological activity and cellular recognition. PDRN works through multiple mechanisms of action, primarily activating the adenosine A2A receptor pathway to stimulate tissue repair, reduce inflammation, and promote angiogenesis.

            Extensive clinical research demonstrates PDRN’s remarkable efficacy in accelerating wound healing, improving skin texture and elasticity, and reducing recovery time in post-procedural care. The compound’s unique polynucleotide chains serve as building blocks for cellular repair while modulating inflammatory responses through cytokine regulation. This dual-action mechanism makes PDRN an ideal active ingredient for advanced aesthetic injections, regenerative skincare formulations, wound care products, and nutraceutical applications.

            Manufactured under strict quality control systems with certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our PDRN guarantees exceptional purity, batch-to-batch consistency, and reliable performance. The raw material undergoes rigorous testing for molecular weight distribution, biological activity, and absence of contaminants, ensuring it meets the highest standards for pharmaceutical and cosmetic applications worldwide. Whether developing next-generation anti-aging products, medical wound healing solutions, or regenerative injectables, our PDRN API provides the scientific foundation for innovative formulations that deliver visible, measurable results.

              Request Product Information

              Please share your requirements below.



              * B2B inquiries only
              * Confidential information protected
              * No spam or marketing emails

              Read moreDone
            • Crosslinked Sodium Hyaluronate Polymer Cosmetic Grade Ingredient

              Premium Crosslinked Sodium Hyaluronate Polymer API for Dermal Fillers & Cosmetics

              .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

              Premium Crosslinked Sodium Hyaluronate Polymer API for Dermal Fillers & Cosmetics

              Crosslinked Sodium Hyaluronate Polymer GMP Certified API Supplier

              Our Crosslinked Sodium Hyaluronate Polymer represents the pinnacle of hyaluronic acid (HA) technology, engineered for superior performance in demanding medical and cosmetic applications. This innovative biotechnological API is created through advanced crosslinking techniques that transform native HA into a robust, three-dimensional gel network. This dense matrix significantly enhances the molecule’s intrinsic properties, delivering exceptional water-binding capacity, remarkable viscoelasticity, and unparalleled resistance to enzymatic and free-radical degradation.

              As a cornerstone ingredient for dermal fillers, this polymer provides the sustained volume, lift, and tissue integration crucial for effective wrinkle correction and facial contouring. Beyond injectables, its unique film-forming and thickening capabilities make it an elite ingredient in high-end skincare, sun care, and hair care products, where it acts as a potent moisturizer and a versatile delivery system for both hydrophilic and lipophilic active compounds.

              Manufactured in ISO 9001, HACCP, and GMP-certified facilities, our polymer guarantees pharmaceutical-grade purity, batch-to-batch consistency, and an ultra-low endotoxin profile (<0.07 EU/mg). We provide unparalleled transparency with verified molecular weight data and stringent quality control, including glucuronic acid content >46% and protein content <0.05%, ensuring your formulations are not only highly effective but also exceptionally safe and stable. Partner with us for a reliable, high-performance HA polymer that elevates your product from standard to exceptional.

                Request Product Information

                Please share your requirements below.



                * B2B inquiries only
                * Confidential information protected
                * No spam or marketing emails

                Read moreDone
              • Recombinant Carboxypeptidase B (CPB) enzyme for pharmaceutical and research applications

                Recombinant Carboxypeptidase B (rCPB) GMP Enzyme for Insulin Purification & Bioprocessing

                .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

                Recombinant Carboxypeptidase B (rCPB) GMP Enzyme for Insulin Purification & Bioprocessing

                Recombinant Carboxypeptidase B GMP Grade Enzyme API Supplier

                Our Recombinant Carboxypeptidase B (rCPB) represents a breakthrough in enzymatic biotechnology, offering pharmaceutical manufacturers a highly pure and efficient solution for precision protein processing. As a zinc-containing exopeptidase, rCPB specifically catalyzes the cleavage of C-terminal basic amino acids (arginine and lysine), making it indispensable in the production of recombinant insulin and other therapeutic proteins. Through advanced recombinant DNA technology, we have engineered a superior enzyme with exceptional catalytic efficiency, thermal stability, and lot-to-lot consistency that far exceeds traditional pancreatic extracts.

                Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our rCPB guarantees exceptional purity (>98% by HPLC), minimal protease contamination, and reliable performance in critical bioprocessing applications. The recombinant production method eliminates risks associated with animal-derived enzymes, ensuring superior safety profiles and compliance with evolving regulatory requirements for biopharmaceutical manufacturing. Each batch undergoes rigorous characterization including mass spectrometry, peptide mapping, and functional activity assays to verify structural integrity and biological performance.

                The global insulin market continues to expand rapidly, driving increased demand for high-quality processing enzymes that can improve yields, reduce production costs, and ensure final product quality. Our rCPB is specifically optimized for the conversion of proinsulin to insulin, efficiently removing C-terminal basic residues with remarkable specificity and speed. Beyond insulin manufacturing, this versatile enzyme finds applications in protein sequencing, peptide mapping, and the production of various biotherapeutics requiring C-terminal modification. With flexible packaging options and comprehensive technical support, we provide pharmaceutical partners with the reliable enzyme solutions needed to advance their bioprocessing capabilities and maintain competitive advantage in global markets.

                  Request Product Information

                  Please share your requirements below.



                  * B2B inquiries only
                  * Confidential information protected
                  * No spam or marketing emails

                  Read moreDone
                • Recombinant KexII Protease enzyme for precise protein cleavage in pharmaceutical and biotechnological applications

                  Recombinant KexII Protease API GMP Grade for Precision Protein Processing & Biopharma

                  .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

                  Recombinant KexII Protease API GMP Grade for Precision Protein Processing & Biopharma

                  Recombinant KexII Protease GMP Enzyme for Biopharmaceutical Manufacturing

                  Recombinant KexII Protease represents a cutting-edge enzymatic solution for precision processing in biopharmaceutical manufacturing. As a calcium-dependent serine protease belonging to the subtilisin family, KexII specifically recognizes and cleaves at paired basic residues (KR- and RR- sites), making it indispensable for the activation of pro-proteins and maturation of recombinant therapeutic peptides. Our recombinant version, produced through advanced microbial expression systems, delivers superior purity, consistency, and activity compared to traditional native preparations, ensuring reliable performance in critical bioprocessing applications.

                  Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our Recombinant KexII Protease guarantees exceptional quality and safety profiles. The enzyme demonstrates remarkable specificity for dibasic cleavage sites while maintaining minimal non-specific proteolytic activity, making it ideal for processing sensitive biopharmaceutical products where precise cleavage is paramount. Through rigorous quality control measures including mass spectrometry, peptide mapping, and functional activity assays, we ensure each batch meets the highest standards for pharmaceutical applications.

                  The global biopharmaceutical market’s rapid expansion, particularly in peptide-based therapeutics and recombinant protein drugs, has created significant demand for high-quality processing enzymes like KexII Protease. Our enzyme is specifically optimized for critical applications including pro-insulin conversion, monoclonal antibody processing, and the activation of various recombinant therapeutic proteins. With its robust performance across diverse pH and temperature conditions, and excellent stability in various buffer systems, our Recombinant KexII Protease enables manufacturers to achieve higher yields, improved product quality, and reduced production costs. Backed by comprehensive technical support and flexible packaging options, we provide biopharmaceutical partners with reliable enzymatic solutions that drive innovation and maintain competitive advantage in global markets.

                    Request Product Information

                    Please share your requirements below.



                    * B2B inquiries only
                    * Confidential information protected
                    * No spam or marketing emails

                    Read moreDone
                  • High-Purity Semaglutide Side Chain – Pharmaceutical Intermediate for GLP-1 Receptor Agonist Synthesis

                    Semaglutide Side Chain API GMP Certified GLP-1 Analog Intermediate for Diabetes & Obesity

                    .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

                    Semaglutide Side Chain API GMP Certified GLP-1 Analog Intermediate for Diabetes & Obesity

                    Semaglutide Side Chain Pharmaceutical Intermediate API Supplier

                    Our Pharmaceutical Grade Semaglutide Side Chain represents a breakthrough in metabolic disease treatment, serving as the critical building block for next-generation GLP-1 receptor agonists. This sophisticated API intermediate features a unique structural modification that enables prolonged receptor activation while resisting degradation by dipeptidyl peptidase-4 (DPP-4), resulting in extended duration of action and reduced dosing frequency. The carefully engineered molecular design provides superior pharmacokinetic profiles, making it essential for developing advanced therapies for type 2 diabetes and chronic weight management.

                    Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our Semaglutide Side Chain guarantees exceptional purity, batch-to-batch consistency, and reliable performance in peptide synthesis. Each batch undergoes rigorous analytical testing using advanced HPLC, MS, and NMR methodologies to verify structural integrity, chiral purity, and absence of process-related impurities. The side chain’s specific chemical properties facilitate efficient conjugation with the peptide backbone while maintaining optimal receptor binding affinity and metabolic stability.

                    As global prevalence of diabetes and obesity continues to rise dramatically, the demand for more effective GLP-1 based therapies has never been greater. Our high-purity side chain intermediate enables pharmaceutical manufacturers to develop advanced semaglutide formulations that offer superior glycemic control, significant weight reduction benefits, and cardiovascular risk reduction. Whether developing innovative injectable formulations or exploring oral delivery systems, our Semaglutide Side Chain API provides the foundational quality and technical excellence required for successful metabolic disease treatment innovations in competitive global markets.

                      Request Product Information

                      Please share your requirements below.



                      * B2B inquiries only
                      * Confidential information protected
                      * No spam or marketing emails

                      Read moreDone